《器官移植后移植物抗宿主病（GVHD）的细胞因子和人类白细胞抗原（HLA）谱》勘误

Erratum to: Cytokine and human leukocyte antigen (HLA) profile for graft-versus-host disease (GVHD) after organ transplantation.

作者信息

Chen Xinhua, Meng Xueqin, Xu Yuning, Xie Haiyang, Yin Shengyong, Li Hongchun, Wu Liming, Zheng Shusen

机构信息

Zhejiang University, School of Medicine, The First Affiliated Hospital, Ministry of Public Health, Key Laboratory Combined Multiorgan Transplant, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, 79 Qingchun Road, Hangzhou, 310003, Zhejiang, People's Republic of China.

Zhejiang University, School of Medicine, The First Affiliated Hospital, The Department of Hepatobiliary Surgery, 79 Qingchun Road, Hangzhou, 310003, Zhejiang, People's Republic of China.

出版信息

Eur J Med Res. 2017 Oct 3;22(1):37. doi: 10.1186/s40001-017-0275-8.

DOI:10.1186/s40001-017-0275-8

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5627485/

Abstract

Following publication of the original article [1], the authors requested a correction in the presentation of their institutions as they appear on the Web of Science. Specifically, it should be emphasized that the institutions belong to Zhejiang University. The correct presentation of affiliations is given in this erratum.

摘要

在原文章[1]发表后，作者要求更正其在科学网上显示的机构信息。具体而言，应强调这些机构隶属于浙江大学。本勘误给出了正确的单位信息。

相似文献

1

Erratum to: Cytokine and human leukocyte antigen (HLA) profile for graft-versus-host disease (GVHD) after organ transplantation.

Eur J Med Res. 2017 Oct 3;22(1):37. doi: 10.1186/s40001-017-0275-8.

2

Cytokine and human leukocyte antigen (HLA) profile for graft-versus-host disease (GVHD) after organ transplantation.

Eur J Med Res. 2016 Oct 12;21(1):38. doi: 10.1186/s40001-016-0232-y.

3

Fatal Graft-Versus-Host Disease Following Adult-To-Adult Living Donor Liver Transplantation From an HLA Nonhomozygous Donor.

Prog Transplant. 2016 Dec;26(4):394-396. doi: 10.1177/1526924816664087. Epub 2016 Sep 20.

4

Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.

Blood Cells Mol Dis. 2008 Jan-Feb;40(1):48-54. doi: 10.1016/j.bcmd.2007.06.019. Epub 2007 Sep 10.

5

Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.

Exp Hematol. 2011 Aug;39(8):880-90. doi: 10.1016/j.exphem.2011.05.007. Epub 2011 May 27.

6

Single-Agent High-Dose Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Human Leukocyte Antigen-Matched Reduced-Intensity Peripheral Blood Stem Cell Transplantation Results in an Unacceptably High Rate of Severe Acute Graft-versus-Host Disease.

Biol Blood Marrow Transplant. 2015 May;21(5):941-4. doi: 10.1016/j.bbmt.2015.01.020. Epub 2015 Jan 27.

7

Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.

Dan Med Bull. 2002 May;49(2):89-108.

8

Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.

Biol Blood Marrow Transplant. 2010 Jun;16(6):838-47. doi: 10.1016/j.bbmt.2010.01.011. Epub 2010 Jan 28.

9

Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching.

Liver Transpl. 2006 Jan;12(1):140-5. doi: 10.1002/lt.20573.

10

Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation.

Transplantation. 2004 Feb 15;77(3):441-6. doi: 10.1097/01.TP.0000103721.29729.FE.

本文引用的文献

1

Cytokine and human leukocyte antigen (HLA) profile for graft-versus-host disease (GVHD) after organ transplantation.

Eur J Med Res. 2016 Oct 12;21(1):38. doi: 10.1186/s40001-016-0232-y.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。